Comments

Harmony Biosciences Hldgs Stock Price, Quotes and Forecasts

Q: What sector and industry does Harmony Biosciences Hldgs (HRMY) operate in?

Harmony Biosciences Hldgs is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

HRMYNASDAQ

Logo brought to you by Benzinga Data

Perks Trade with Public

$34.00

-0.33-0.96%

At close: -

$34.00

0.000.00%

After Hours: Jul 11, 4:00 PM EDT

Harmony Biosciences Hldgs (HRMY) Forecast

News Earnings Harmony Biosciences Hldgs (HRMY) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings

Harmony Biosciences Hldgs Stock Price, Quotes and Forecasts | NASDAQ:HRMY | Benzinga

Explore Harmony Biosciences Hldgs stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for HRMY.

Open	$34.17
Close	$34.00
Volume / Avg.	370.56K / 676.56K
Day Range	$33.76 - $34.57
52 Wk Range	26.47 - 41.61
Market Cap	$1.95B
P/E Ratio	13.09
Dividend Yield	-
Exchange	NASDAQ
RSI	59
Short Interest	16.87%
Days to Cover	6.65

Recent News

Harmony Biosciences Stock Falls On FDA Setback For Pitolisant In Sleeping Disorder

Harmony Biosciences' FDA setback for pitolisant in idiopathic hypersomnia doesn't impact its 2025 revenue outlook, with a Phase 3 trial planned for late 2025.

Vandana Singh

Why Harmony Biosciences (HRMY) Stock Is Down 18% Today

Harmony Biosciences shares are trading lower by 17% Wednesday afternoon. The company announced a public offering of up to 8 million common stock shares from selling shareholders.

Henry Khederian

Neurology-Focused Harmony Biosciences Gains Confidence With Wakix Sales Surge, Strategic Pipeline Expansion, Bullish Analyst Says

UBS has initiated coverage on Harmony Biosciences with a Buy rating and a price target of $56. UBS highlights Harmony's potential for growth, projecting a 19% CAGR for Wakix sales through 2026.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Mar

Apr

May

Jun

Jul

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$34.17
Close	$34.00
Volume / Avg.	370.56K / 676.56K
Day Range	$33.76 - $34.57
52 Wk Range	26.47 - 41.61
Market Cap	$1.95B
P/E Ratio	13.09
Dividend Yield	-
Exchange	NASDAQ
RSI	59
Short Interest	16.87%
Days to Cover	6.65

About Harmony Biosciences Holdings Inc

Sector

Health Care

Industry

Pharmaceuticals

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing ...

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

How do I buy Harmony Biosciences Hldgs (HRMY) stock?

You can purchase shares of Harmony Biosciences Hldgs (NASDAQ:HRMY) through any online brokerage.

View our list of the best stock brokerages

Who are Harmony Biosciences Hldgs (HRMY) competitors?

Other companies in Harmony Biosciences Hldgs’s space includes: WAVE Life Sciences (NASDAQ:WVE), Verona Pharma (NASDAQ:VRNA), Supernus Pharmaceuticals (NASDAQ:SUPN), Tarsus Pharmaceuticals (NASDAQ:TARS) and Phibro Animal Health (NASDAQ:PAHC).

What is the forecast, or price target, for Harmony Biosciences Hldgs (HRMY) stock?

Harmony Biosciences Hldgs has a consensus price target of $50.53.

What is the current price for Harmony Biosciences Hldgs (HRMY)?

The stock price for Harmony Biosciences Hldgs (NASDAQ: HRMY) is $34 last updated July 11, 2025 at 4:00 PM EDT.

Does Harmony Biosciences Hldgs (HRMY) pay a dividend?

There are no upcoming dividends for Harmony Biosciences Hldgs.

When is Harmony Biosciences Hldgs (NASDAQ:HRMY) reporting earnings?

Harmony Biosciences Hldgs’s Q2 earnings are confirmed for Tuesday, August 5, 2025.

Is Harmony Biosciences Hldgs (HRMY) going to split?

There is no upcoming split for Harmony Biosciences Hldgs.

What sector and industry does Harmony Biosciences Hldgs (HRMY) operate in?

Harmony Biosciences Hldgs is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.